Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease

MLA

Panpan Chen, et al. “Integrated Spatial Metabolomics and Transcriptomics Decipher the Hepatoprotection Mechanisms of Wedelolactone and Demethylwedelolactone on Non-Alcoholic Fatty Liver Disease.” Journal of Pharmaceutical Analysis, vol. 14, no. 4, Apr. 2024. EBSCOhost, https://doi.org/10.1016/j.jpha.2023.11.017.

APA

Panpan Chen, Zihan Zhu, Haoyuan Geng, Xiaoqing Cui, Yuhao Han, Lei Wang, Yaqi Zhang, Heng Lu, Xiao Wang, Yun Zhang, & Chenglong Sun. (2024). Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease. Journal of Pharmaceutical Analysis, 14(4). https://doi.org/10.1016/j.jpha.2023.11.017

Chicago

Panpan Chen, Zihan Zhu, Haoyuan Geng, Xiaoqing Cui, Yuhao Han, Lei Wang, Yaqi Zhang, et al. 2024. “Integrated Spatial Metabolomics and Transcriptomics Decipher the Hepatoprotection Mechanisms of Wedelolactone and Demethylwedelolactone on Non-Alcoholic Fatty Liver Disease.” Journal of Pharmaceutical Analysis 14 (4). doi:10.1016/j.jpha.2023.11.017.